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One of the most common fragility fracture and a fracture asso-
ciated with increased morbidity and mortality is the vertebral 
compression fracture (Hasserius et al. 2005). The incidence 
varies, being higher in Scandinavian, American, and Hong 
Kong Chinese females than in eastern European females. In 
contrast, the incidence in male Hong Kong Chinese and Amer-
ican Caucasians is lower than in male Europeans (Melton et 
al. 1993, Lau et al. 1996, O’Neill et al. 1996). The female-
to-male  ratio  in  Caucasians  is  2:1,  with  an  age-dependent 
increase in both men and women, giving an incidence of 20 
per 105 person-years in individuals below 45 years of age and 
1,200 per 105 person-years in those aged 85 years and above 
(O’Neill et al. 1996).
In  light  of  the  enormous  costs  and  the  negative  health 
aspects associated with vertebral fractures, percutaneous ver-
tebroplasty and kyphoplasty were introduced. Vertebroplasty 
by  percutaneous  injection  of  bone  cement  was  originally 
developed in France, and in 1987 it was first reported as one 
strategy for stabilizing vertebral bodies affected by a tumor 
(Galibert et al. 1987). In 1989, the method was also shown 
to  stabilize  fractured  osteoporotic  vertebrae  (Lapras  et  al. 
1989). Vertebroplasty was hypothetically improved by intro-
duction of the percutaneous balloon kyphoplasty technique 
(Lieberman et al. 2001). This involves inflating a balloon in 
the fractured vertebral body in order to restore the anatomy of 
the fractured vertebra and reduce the fracture-induced kypho-
sis. The void created is then filled with bone cement. Both 
methods immediately attracted a great amount of interest. A 
Medline search in Oct 2004 identified 388 articles on “verte-
broplasty” and 92 on “kyphoplasty”. A similar search in Jan 
2010 resulted in 1,398 hits for “vertebroplasty” and 1,573 for 
“kyphoplasty”. 
The two techniques, the short-term clinical results, and the 
possible  complications  have  all  been  thoroughly  reported 
(Lieberman et al. 2001, Diamond et al. 2003), but up until now 
there have been no prospective randomized controlled trials 
(RCTs) published regarding the efficacy of the procedures. 
Case reports, prospective and retrospective uncontrolled short-
term observational studies, and case-control studies have con-
sistently inferred an almost immediate relief of back pain and 
improved functional status after such procedures in 75–90% 
of cases (Lieberman et al. 2001, Diamond et al. 2003). These 
results are based on different estimates of pain relief and have 
mainly been compared to the preoperative situation but with-
out comparison with controls. Whether or not vertebroplasty 
or kyphoplasty gives a better outcome than medical treatment 
is still not known. 
Recently, however, several RCTs have improved our under-
standing (Rauschmann et al. 2004, Gray et al. 2007, Buchbin-
der et al. 2008, 2009, Kallmes et al. 2009, Wardlaw et al. 2009, 
Liu et al. 2010). Two multicenter, randomized, double-blind 
placebo-controlled trials presented in New England Journal 
of Medicine (NEJM) (Buchbinder et al. 2009, Kallmes et al. 
2009)—one study from Australia and one from the USA, of 
which both  denied beneficial effects of vertebroplasty in com-
parison with medical treatment in patients with osteoporotic 
vertebral compression fractures—have been debated over the 
last months. In the Australian study, participants with 1 or 2 
painful osteoporotic vertebral fractures confirmed by MRI and 
with less than 1 year’s duration underwent vertebroplasty (n = 
35) or a sham procedure (n = 40). Participants were stratified 
according to duration of symptoms (of less than 6 weeks or 6 
weeks or more), and the primary outcome (overall pain) was 
evaluated after 1 week and at 1, 3, and 6 months. Secondary 
outcomes were pain at night, pain at rest, physical function, 
quality of life, and perceived improvement. This report stated 
that there were substantial reductions in overall pain in both 
study groups, and that vertebroplasty was not better in any 
measured outcome at any time compared to the controls. The 
outcome was the same in individuals with less or more than 6 
weeks of pain (Buchbinder et al. 2009).
In  the  other  study,  this  time  from  the  Mayo  Clinic,  the 
researchers randomly assigned 131 patients who had 1 to 3 
painful osteoporotic vertebral compression fractures to either 
vertebroplasty (n = 68) or a simulated procedure without cement 
(n = 63). The primary outcomes were assessed using the modi-
fied Roland-Morris disability questionnaire (RDQ) score and 
the patient ratings of pain intensity during the 24 hours after the 
operation and also after 1 month. The patients were allowed to 
cross over to the other study group after 1 month. This report 
stated that there was major improvement in the outcome mea-
sures in both the vertebroplasty group and the control group and 
that vertebroplasty did not result in any advantage in measured 
outcome variables at any time compared to the controls. There 
was, however, a trend toward beneficial clinical improvement in 
pain in the vertebroplasty group (64% vs. 48%; p = 0.06) after 
1 month and at 3 months. The crossover rate was also higher 
in the control group than in the vertebroplasty group (43% vs. 
12%; p < 0.001) (Kallmes et al. 2009)
A third RCT has supported the 2 NEJM publications, this 
time involving 50 patients with acute or subacute osteoporotic 
vertebral fractures (< 2 weeks and between 2 and 8 weeks, 
respectively) who were randomized to either vertebroplasty 
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was similar in the 2 groups and that there was no statistically 
significant difference in the other parameters when comparing 
the results at inclusion and after 3 months within both groups, 
and virtually none between the groups after 3 months (Rous-
ing et al. 2009). The authors concluded that most patients with 
acute or subacute painful osteoporotic compression fractures 
of the spine will spontaneously recover after a few months. 
This view is opposed by other authors, however, who have 
suggested that as many as 75% of patients with an osteopo-
rosis-related vertebral fracture still have pain 1 year after the 
event (Suzuki et al. 2008, 2009, 2010).
These RCTs have been criticized (Clark et al. 2009). Verte-
broplasty aims at internal fixation of non-healed osteoporotic 
vertebral fractures to reduce pain, similar to that obtained by 
internal fixation with other acute fractures. However, verte-
bral fractures usually heal within 8 weeks, whereas the edema 
found  in  MRI  evaluations  persists  for  an  extended  period. 
There is no strict definition regarding time limits when a frac-
ture should be defined as acute, as subacute, or as one with 
delayed union. The study by Kallmes et al. (2009) involved 
only  outpatients,  so  that  inpatients  hospitalized  with  acute 
fracture pain were excluded and the protocol required 4 weeks 
of medical therapy before enrollment was possible. Critics 
therefore suggest that these enrollment criteria would have 
resulted in a study on healed fractures where another source 
of pain should have been considered. According to the critics, 
a more appropriate selection criterion would have been uncon-
trolled pain for less than 6 weeks, which was found in only 
32% of the subjects in the study reported by Buchbinder et al. 
(2009) and in 44% of the subjects reported by Kallmes et al. 
(2009). The trial by Buchbinder et al. was planned to involve 
200 patients but only 78 were actually included over 4 years 
in the final study; this was because 2 of the 4 study hospi-
tals withdrew after including only 5 patients each. As a result, 
68% of the procedures were performed in one hospital by one 
radiologist. Finally, 64% of eligible patients in the Australian 
study and 70% in the US study declined to participate. All 
these concerns raise questions regarding patient selection and 
generalization of inferences. 
Some critics have also suggested that the study design was 
inappropriate, as not all patients with a vertebral fracture ben-
efit from a vertebroplasty (Clark et al. 2009). In many stud-
ies, patients with maximal back pain tend to have the greatest 
improvement in pain score after vertebroplasty—more so than 
those with a lower degree of pain—and there has been concern 
that the level of pain in the patients in the RCTs cited was 
lower than in most patients with vertebral fractures. Enroll-
ment of only those patients with the most severe pain might, 
however, lead to exaggeration of treatment efficacy due to 
regression toward the mean effect. One could also question 
whether patients who receive an injection of an anesthetic 
should be regarded as unbiased controls, since local anesthetic 
can have effects for a period exceeding the pharmacological 
activity of the drug. The larger crossover rates reported by 
Kallmes et al. (2009) that occurred in the control group than 
in the treatment group could possibly indicate dissatisfaction 
with the sham procedure that was not captured by pain scales. 
But as nearly all crossovers occurred after 1 month and the 
primary outcome was evaluated after 1 month, this should not 
have affected the primary outcome evaluation.
The  efficacy  of  balloon  kyphoplasty  in  the  treatment  of 
vertebral osteoporotic fractures has now also been evaluated 
in  one  multicenter  RCT  involving  149  kyphoplasty-treated 
patients  and  151  non-surgically  treated  patients  with  1–3 
acute vertebral fractures (Wardlaw et al. 2009). The primary 
outcome was changes from baseline to 1 month, as assessed 
by SF-36 and at 12 months in quality-of-life evaluation. Both 
groups improved in terms of quality of life, the kyphoplasty 
group by an average of 7.2 points (95% CI: 5.7–8.8) and the 
group that did not undergo surgery by an average of 2.0 points 
(95% CI: 0.4–3.6), a group difference of 5.2 points on aver-
age (95% CI: 2.9–7.4). The authors then inferred that balloon 
kyphoplasty is an effective procedure for patients with acute 
vertebral  fractures.  However,  substantial  improvement  was 
found in both the operated group and in the group that was 
not operated. Even though there was a group difference in the 
outcome score, it can be debated whether the difference was 
of clinical relevance.  In addition, during the 1-year follow-up, 
21 of the participants in the kyphoplasty group (14%) had new 
vertebral fractures, in several cases causing a need for new 
surgical intervention.
There have also been very few studies directly comparing 
percutaneous balloon kyphoplasty with percutaneous vertebro-
plasty. This ought to be done, as there could conceivably be 
advantages to using the kyphoplasty method since it aims to 
restore the normal anatomy of the fractured vertebra to reduce 
the kyphosis in the injured region. By inflating a balloon in the 
fractured vertebral body, kyphoplasty seeks to recreate the orig-
inal shape of the compressed vertebral body before the cement 
fixation. However, it has so far been difficult to show any clini-
cal advantages that justify the higher cost of kyphoplasty rela-
tive to vertebroplasty. Recently, both methods were compared 
in  a  randomized  controlled  trial  that  included  100  patients, 
where the authors reported that the clinical outcome after 6 
months was similar in both treatment groups (Liu et al. 2010).
It is not only important to evaluate whether there is a differ-
ence in clinical outcome between surgical and non-surgical 
treatment, however. All new methods should also be assessed 
in terms of cost in relation to quality of life. The term cost 
per QUALY is often used, a term that includes cost per gain 
in quality-adjusted years of life. There has been a publication 
dealing with this question, mostly based on the assumption 
that reported short-term effects achieved with vertebroplasty 
and  kyphoplasty  remain  in  the  long  term  (Wardlaw  et  al. 
2009). Using “willingness to pay” (WTP) of 60,000 euros, 
some of the theoretical models used in the study suggested 
that the methods could be cost-effective (Strom et al. 2008). 
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term follow-up and including both clinical outcome and costs 
to society—before we can draw stricter conclusions about the 
cost-effectiveness of the methods.
Generally  speaking,  we  should  discontinue  a  treatment 
when there is convincing evidence that it provides little or no 
effect. The reported RCTs on vertebroplasty (Gray et al. 2007, 
Buchbinder et al. 2009, Kallmes et al. 2009, Rousing et al. 
2009) provide the best evidence we have to date regarding the 
efficacy of this method for the treatment of osteoporotic verte-
bral compression fractures. The repeated findings of improve-
ment in pain in both intervention and control groups and the 
lack of benefit in the intervention group relative to the con-
trol group seems to reflect the benign natural history of pain 
development in vertebral compression fractures in the elderly. 
It must then be regarded as questionable to offer patients an 
intervention that is no more effective, is more expensive, and 
sometimes more dangerous than placebo (Buchbinder et al. 
2008). Most patients, when receiving this information, will 
probably choose a medical and less risky treatment of the 
pain. The results of the RCTs should once more remind us to 
be cautious in using treatments based on data with a low level 
of evidence. Case reports and observational studies are often 
biased toward overestimating treatment benefits. Thus, verte-
broplasty appears to confer no benefit over a sham procedure 
or medical care, and it involves adverse risks associated with 
the operation. In contrast to this, one RCT has shown a statisti-
cally significant improvement in the quality of life score after 
1 month in a group of patients operated with balloon kypho-
plasty in comparison with a group subjected to non-surgical 
care (Wardlaw et al. 2009). Whether this difference represents 
not only a statistically significant difference but also a clini-
cally relevant difference should be evaluated in future studies. 
In conclusion, lack of evidence of efficacy when advocating 
vertebroplasty in the treatment of osteporotic vertebral frac-
tures is stronger than the proof of efficacy when using kypho-
plasty. The results of published RCTs should lead to the dis-
continuation of vertebroplasty as a general treatment modality 
for vertebral compression fractures with persistent pain in the 
elderly osteoporotic patient, while balloon kyphoplasty ought 
to be evaluated in further studies before definite recommenda-
tions can be given. 
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